Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pancreatitis - Microbiome as Predictor of Severity II

NCT06508502 is registered in ClinicalTrials.gov with University Medical Center Goettingen as lead sponsor.

NCT NCT06508502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06508502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pancreatitis - Microbiome as Predictor of Severity II
Lead sponsor
University Medical Center Goettingen
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2024
Completion date
December 31, 2027
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pancreatitis, acute pancreatitis with infected necrosis